Beijing Tongren Hospital
221
39
42
68
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.8%
4 terminated/withdrawn out of 221 trials
94.4%
+7.9% vs industry average
13%
28 trials in Phase 3/4
0%
0 of 68 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (221)
Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC
Role: lead
Retinal Clinical Assessment With AI-derived Quantitative Information
Role: lead
Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma
Role: lead
PaCIFiC-CUP Classifies Cancer of Unknown Primary
Role: collaborator
CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma
Role: lead
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Role: lead
Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)
Role: lead
Antagonism of Neostigmine in Continuous Infusion of Mivacurium
Role: lead
Evaluating App-Based Vision Testing (WHOeyes) Combined With the Questionnaire as a Substitute for One-Week Postoperative In-Clinic Follow-Up in Age-Related Cataract Patients: A Multi-center Randomized Controlled Trial
Role: collaborator
Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis
Role: lead
Auricular Acupressure for Reducing Postoperative Emergence Agitation in Preschool Children
Role: lead
Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL
Role: collaborator
Evaluation of the Efficacy of Red Light in Adult Patients With High and Extreme Myopia
Role: lead
Low Concentration Atropine Combined With Soft Contact Lens in Controlling Myopia Progression in Children With High Myopia
Role: lead
Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia
Role: lead
Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma
Role: lead
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Role: lead
Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
Role: collaborator
Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression
Role: lead
Evaluating the Effectiveness of Comfort Reading Mode in Preventing Dry Eyes and Visual Fatigue
Role: lead